6Kong HH,Cowen EW,Azad NS,et al.Keratoacanthomas associated with sorafenib therapy.J Am Acad Dermatol,2007,56:171-172.
7Chung NM,Gutierrez M,Turner ML.Leukocytoclastic vasculitis masquerading as hand-foot syndrome in a patient treated with sorafenib.Arch Dermatol,2006,142:1510-1511.
8Strumberg D, Clark JW, Awada A, et al. Safety,pharmacokinetics,and preliminary antitumor activity of sorafenib:a review of four phase Ⅰ trials in patients with advanced refractory solid tumors.Oncologist,2007,12:426-437.
9Yang CH,Lin WC,Chuang CK,et al.Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinas einhibitor therapy.Br J Dermatol,2008,158:592-596.
10Azad NS,Aragon-Ching JB,Dahut WL,et al.Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy.Clin Cancer Res,2009,15:1411-1416.
